Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie | Panstwowy Instytut Badawczy, Oddzial w Krakowie

Research site
ul. Garncarska 11, Krakow, Malopolskie, Poland
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


1 of 1
Status: Active
Trial type: Interventional
Funder type: Industry

Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH

Researchers in this study want to compare how well drug radium-223 dichloride (Xofigo) and new (novel) anti-hormonal (NAH) therapy work in participan...

Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Drug: NAH therapy
Drug: Radium-223 dichloride (Xofigo, BAY88-8223)

Trial conditions

Prostatic Cancer (1 trial)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems